(Q33578187)

28 July 2017

1 reference

title

PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed (English)

1 reference

28 July 2017

4

Alexander Drzezga

0 references

author name string

Benjamin D Kläsner

series ordinal

1

1 reference

28 July 2017

Bernd J Krause

series ordinal

2

1 reference

28 July 2017

Ambros J Beer

series ordinal

3

1 reference

28 July 2017

publication date

1 May 2010

1 reference

Expert Review of Anticancer Therapy

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

609-613

1 reference

28 July 2017

cites work

PET in neuro-oncology

1 reference

21 January 2018

Cancer statistics, 2005

1 reference

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

Imaging gliomas with positron emission tomography and single-photon emission computed tomography

21 January 2018

1 reference

Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study

21 January 2018

1 reference

11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.

21 January 2018

1 reference

Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)

21 January 2018

1 reference

O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study

21 January 2018

1 reference

Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas

21 January 2018

1 reference

Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma

21 January 2018

1 reference

Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures

21 January 2018

1 reference

11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.

21 January 2018

1 reference

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma

21 January 2018

1 reference

Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value

21 January 2018

1 reference

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

21 January 2018

1 reference

Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma

21 January 2018

1 reference

Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy

21 January 2018

1 reference

Early metabolic responses in temozolomide treated low-grade glioma patients

21 January 2018

1 reference

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

21 January 2018

Imaging in neurooncology

1 reference

Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy

21 January 2018

1 reference

Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose

21 January 2018

1 reference

Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology

21 January 2018

1 reference

Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma.

21 January 2018

1 reference

O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma

21 January 2018

1 reference

Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma

21 January 2018

1 reference

Early evaluation of tumour metabolic response using [18F]fluorodeoxyglucose and positron emission tomography: a pilot study following the phase II chemotherapy schedule for temozolomide in recurrent high-grade gliomas

21 January 2018

1 reference

Positron emission tomography with injection of methionine as a prognostic factor in glioma

21 January 2018

1 reference

Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas

21 January 2018

1 reference

The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma

21 January 2018

1 reference

FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

21 January 2018

1 reference

Positron emission tomography in patients with glioma. A predictor of prognosis.

21 January 2018

1 reference

New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose

21 January 2018

1 reference

Prediction of pathology and survival by FDG PET in gliomas

21 January 2018

1 reference

[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors

21 January 2018

1 reference

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

21 January 2018

1 reference

Imaging of integrin alphavbeta3 expression

21 January 2018

1 reference

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature

21 January 2018

1 reference

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

21 January 2018

1 reference

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

21 January 2018

1 reference

Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography

21 January 2018

1 reference

Simultaneous PET-MRI: a new approach for functional and morphological imaging

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.10.37

1 reference

28 July 2017

1 reference